Differentiation Between Acinetobacter Baumannii Colonization and Infection and the Clinical Outcome Prediction by Infection in Lower Respiratory Tract

References

• Khammarnia M, Ansari-Moghaddam A, Barfar E, et al. Systematic review and meta-analysis of hospital acquired infections rate in a Middle East country (1995–2020). Med J Islam Repub Iran. 2021;35:102. PMID: 34956948; PMCID: PMC8683797. doi:10.47176/mjiri.35.102
   Google Scholar
• Vo-Pham-Minh T, Duong-Thi-Thanh V, Nguyen T, et al. The impact of risk factors on treatment outcomes of nosocomial pneumonia due to gram-negative bacteria in the intensive care unit. Pulm Ther. 2021; (2):563–574. PMID: 34652610; PMCID: PMC8517295. doi:10.1007/s41030-021-00175-4
   Google Scholar
• Mazloomirad F, Hasanzadeh S, Sharifi A, Nikbakht G, Roustaei N, Khoramrooz SS. Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran; evaluation of biofilm production and molecular typing of bacterial isolates. BMC Pulm Med. 2021;21(1):408. PMID: 34886838; PMCID: PMC8662843. doi:10.1186/s12890-021-01773-3
   PubMed Web of Science ®Google Scholar
• Feng DY, Zhou YQ, Zou XL, et al. Differences in microbial etiology between hospital-acquired pneumonia and ventilator-associated pneumonia: a single-center retrospective study in Guang Zhou. Infect Drug Resist. 2019;12:993–1000. doi:10.2147/IDR.S204671
   Web of Science ®Google Scholar
• Ko RE, Min KH, Hong SB, et al. Korean HAP/VAP study group. characteristics, management, and clinical outcomes of patients with hospital-acquired and ventilator-associated pneumonia: a multicenter cohort study in Korea. Tuberc Respir Dis. 2021;84:317–325. PMID: 34134465; PMCID: PMC8497766. doi:10.4046/trd.2021.0018
   Web of Science ®Google Scholar
• Shi Y, Huang Y, Zhang TT, et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). J Thorac Dis. 2019;11(6):2581–2616. PMID: 31372297; PMCID: PMC6626807. doi:10.21037/jtd.2019.06.09
   PubMed Web of Science ®Google Scholar
• Jorgensen JH, Pfaller MA, Carroll KC, et al. Manual of Clinical Microbiology. 11th. Washington: American Society of Microbiology; 2015.
   Google Scholar
• CLSI. Performance standards for antimicrobial susceptibility testing. 30sted. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Borja AJ, Connolly J, Kvint S, et al. Charlson Comorbidity Index score predicts adverse post-operative outcomes after far lateral lumbar discectomy. Clin Neurol Neurosurg. 2021;206:106697. PMID: 34030078. doi:10.1016/j.clineuro.2021.106697
   Web of Science ®Google Scholar
• Fujitani S, Yu VL. Diagnosis of ventilator-associated pneumonia: focus on nonbronchoscopic techniques (nonbronchoscopic bronchoalveolar lavage, including Mini-BAL, blinded protected specimen brush, and blinded bronchial sampling) and endotracheal aspirates. J Intensive Care Med. 2006;21:17–21. doi:10.1177/0885066605283094
   Google Scholar
• da Fonseca AS, Mencalha AL, de Paoli F. Antimicrobial photodynamic therapy against Acinetobacter baumannii. Photodiagnosis Photodyn Ther. 2021;35:102430. PMID: 34233224. doi:10.1016/j.pdpdt.2021.102430
   Web of Science ®Google Scholar
• Gordon NC, Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J Clin Microbiol. 2009;47:2249–2251. doi:10.1128/JCM.00634-09
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski LA. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect Immun. 2000;68:6511–6518. doi:10.1128/IAI.68.12.6511-6518.2000
   PubMed Web of Science ®Google Scholar
• Carrasco E, Gómez de Las Heras MM, Gabandé-Rodríguez E, Desdín-Micó G, Aranda JF, Mittelbrunn M. The role of T cells in age-related diseases. Nat Rev Immunol. 2022;22(2):97–111. PMID: 34099898. doi:10.1038/s41577-021-00557-4
   PubMed Web of Science ®Google Scholar
• Zarkesh M, Sedaghat F, Heidarzadeh A, Tabrizi M, Bolooki-Moghadam K, Ghesmati S. Diagnostic value of IL-6, CRP, WBC, and absolute neutrophil count to predict serious bacterial infection in febrile infants. Acta Med Iran. 2015;53(7):408–411. PMID: 26520627.
   PubMedGoogle Scholar
• Jean SS, Chang YC, Lin WC, Lee WS, Hsueh PR, Hsu CW. Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia. J Clin Med. 2020;9(1):275. PMID: 31963877; PMCID: PMC7019939. doi:10.3390/jcm9010275
   Web of Science ®Google Scholar
• Shu H, Li L, Wang Y, et al. Prediction of the risk of hospital deaths in patients with hospital-acquired pneumonia caused by multidrug-resistant Acinetobacter baumannii infection: a multi-center study. Infect Drug Resist. 2020;13:4147–4154. PMID: 33244244; PMCID: PMC7683351. doi:10.2147/IDR.S265195
   Web of Science ®Google Scholar
• Jiao J, Li Z, Wu X, et al. Risk factors for 3-month mortality in bedridden patients with hospital-acquired pneumonia: a multicentre prospective study. PLoS One. 2021;16(3):e0249198. PMID: 33784317; PMCID: PMC8009424. doi:10.1371/journal.pone.0249198
   Web of Science ®Google Scholar
• Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–e12. PMID: 32283162; PMCID: PMC7195072. doi:10.1016/j.jinf.2020.04.002
   Web of Science ®Google Scholar
• Zou XL, Feng DY, Wu WB, Yang HL, Zhang TT. Blood urea nitrogen to serum albumin ratio independently predicts 30-day mortality and severity in patients with Escherichia coli bacteraemia. Med Clin (Barc). 2021. 157(5):219–225. English, Spanish. PMID: 33059940. doi:10.1016/j.medcli.2020.06.060
   Web of Science ®Google Scholar
• Akahane J, Ushiki A, Kosaka M, et al. Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection. J Infect Chemother. 2021;27(5):707–714. PMID: 33376033. doi:10.1016/j.jiac.2020.12.017
   PubMed Web of Science ®Google Scholar
• von Dach E, Albrich WC, Brunel AS, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323(21):2160–2169. PMID: 32484534; PMCID: PMC7267846. doi:10.1001/jama.2020.6348
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang S, Li L, Xie J. The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients. Arch Gerontol Geriatr. 2019;80:53–57. PMID: 30366226. doi:10.1016/j.archger.2018.10.005
   PubMed Web of Science ®Google Scholar
• Monajati M, Ala S, Aliyali M, et al. Clinical effectiveness of a high dose versus the standard dose of meropenem in ventilator-associated pneumonia caused by multidrug resistant bacteria: a randomized, single-blind clinical trial. Infect Disord Drug Targets. 2021;21(2):274–283. PMID: 32106807. doi:10.2174/1871526520666200227102013
   Google Scholar
• Ren J, Li X, Wang L, Liu M, Zheng K, Wang Y. Risk factors and drug resistance of the MDR Acinetobacter baumannii in pneumonia patients in ICU. Open Med. 2019;14:772–777. PMID: 31667355; PMCID: PMC6814959. doi:10.1515/med-2019-0090
   Web of Science ®Google Scholar
• Butler DA, Biagi M, Tan X, Qasmieh S, Bulman ZP, Wenzler E. Multidrug resistant Acinetobacter baumannii: resistance by any other name would still be hard to treat. Curr Infect Dis Rep. 2019;21(12):46. PMID: 31734740. doi:10.1007/s11908-019-0706-5
   Web of Science ®Google Scholar
• Zhang Y, Shou S. Pathogens and drug-resistance of hospital-acquired pneumonia in an EICU in Tianjin, China. Int J Biochem Mol Biol. 2021;12(2):49–54. PMID: 34084593; PMCID: PMC8166653.
   PubMedGoogle Scholar
• Hamade B, Huang DT. Procalcitonin: where are we now? Crit Care Clin. 2020;36(1):23–40. PMID: 31733680; PMCID: PMC6866676. doi:10.1016/j.ccc.2019.08.003
   PubMed Web of Science ®Google Scholar
• Wussler D, Kozhuharov N, Tavares Oliveira M, et al. Clinical utility of procalcitonin in the diagnosis of pneumonia. Clin Chem. 2019;65(12):1532–1542. PMID: 31615771. doi:10.1373/clinchem.2019.306787
   PubMed Web of Science ®Google Scholar
• Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538–542. doi:10.1093/cid/ciz545
   PubMed Web of Science ®Google Scholar
• Lakshmi VS, Cherian A, Adole P. Procalcitonin assay has no role in the routine assessment of severe trauma patients at admission to the emergency department. Cureus. 2021;13(7):e16228. PMID: 34268060; PMCID: PMC8262111. doi:10.7759/cureus.16228
   Web of Science ®Google Scholar
• Bowman C, Covington EW. Determination of the optimal procalcitonin threshold for infection in patients with impaired renal function at a community hospital. J Pharm Technol. 2020;36(4):157–163. PMID: 34752523; PMCID: PMC7359663. doi:10.1177/8755122520924803
   PubMed Web of Science ®Google Scholar